Pfizer (PFE)
24.51
+0.28 (1.16%)
NYSE · Last Trade: Oct 18th, 6:55 AM EDT
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY)
fell 3.5% in the afternoon session after political comments introduced significant uncertainty regarding the future pricing of the company’s weight-loss and diabetes drugs, Zepbound and Mounjaro.
Via StockStory · October 17, 2025
INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announcements aimed at making fertility treatments more affordable and accessible.
Via Benzinga · October 17, 2025
NICE recommends ViiV Healthcare's Apretude as the first injectable PrEP for HIV prevention, offering an alternative to daily oral medication.
Via Benzinga · October 17, 2025
Via The Motley Fool · October 17, 2025
Pfizer CEO Urges US-China Collaboration In Pharma; Stock Drops For 7th Day As Traders Hold For Dividend Payoutstocktwits.com
Via Stocktwits · October 14, 2025
Trump's promise to cut cost of Novo Nordisk A/S drug Ozempic from $1,300 to $150 shakes GLP-1 gold rush, with potential impact on Eli Lilly and Pfizer.
Via Benzinga · October 17, 2025
Eli Lilly said Friday a combo using Verzenio cut the risk of death by nearly 16% over two years for breast cancer patients.
Via Investor's Business Daily · October 17, 2025
Via The Motley Fool · October 16, 2025
Artificial intelligence (AI) stands at the precipice of a profound transformation in healthcare, promising a future where diagnostics are sharper, treatments are more personalized, and patient care is more accessible and efficient. This digital revolution, however, is unfolding amidst a complex landscape of groundbreaking scientific advancements and pervasive misinformation, making it crucial to discern genuine [...]
Via TokenRing AI · October 16, 2025
As of October 16, 2025, the U.S. stock market is a tapestry woven with threads of robust corporate earnings, groundbreaking technological advancements, and persistent geopolitical and economic uncertainties. While the Dow Jones Industrial Average (DJIA), S&P 500, and Nasdaq Composite have demonstrated remarkable resilience, often pushing to new
Via MarketMinute · October 16, 2025
Via The Motley Fool · October 16, 2025
Via The Motley Fool · October 16, 2025
It's the best time in a while to scoop up shares of this stock from the discount bin.
Via The Motley Fool · October 16, 2025
Moderna's sales have plummeted in recent years along with diminishing demand for COVID vaccines.
Via The Motley Fool · October 15, 2025
In a year marked by evolving market dynamics and a persistent search for both growth and stability, two distinct titans of industry—Meta Platforms (NASDAQ: META) and Johnson & Johnson (NYSE: JNJ)—have emerged as standout performers for dividend-seeking investors. As of October 15, 2025, these companies represent compelling examples of
Via MarketMinute · October 15, 2025
Wall Street witnessed a significant shift this Wednesday as an eagerly anticipated earnings push ultimately petered out, sending stocks into the red. This downturn followed a volatile Tuesday, which saw markets grappling with fresh developments in the ongoing U.S.-China trade saga. Despite earlier indications of a rebound with
Via MarketMinute · October 15, 2025
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Wednesday and uncover the stocks that are leading the way in terms of trading volume and market attention.
Via Chartmill · October 15, 2025
According to a report from Bloomberg, Bourla said that it's harder to get vaccine approvals and not drug approvals.
Via Stocktwits · October 15, 2025
Via Benzinga · October 15, 2025
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Via StockStory · October 15, 2025
A groundbreaking wave of Artificial Intelligence (AI) tools is poised to fundamentally transform materials quality checking, ushering in an era of unparalleled precision, speed, and cost-efficiency across critical industries. This new AI tool has made checking the quality of materials significantly easier, with profound and immediate implications for sectors such
Via MarketMinute · October 14, 2025
The United States government is currently in the throes of its third week of a shutdown, a fiscal impasse that commenced on October 1, 2025, following a congressional failure to enact appropriations legislation for the 2026 fiscal year. This eleventh government shutdown in U.S. history is sending ripples of
Via MarketMinute · October 14, 2025
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest trading volume and driving market activity.
Via Chartmill · October 14, 2025
Pfizer's Tukysa improved progression-free survival in first-line HER2+ metastatic breast cancer, showing strong efficacy and a manageable safety profile.
Via Benzinga · October 14, 2025
Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least $5 billion.
Via Benzinga · October 14, 2025